170 related articles for article (PubMed ID: 34046603)
61. Theoretical Insights into the Anti-SARS-CoV-2 Activity of Chloroquine and Its Analogs and In Silico Screening of Main Protease Inhibitors.
Achutha AS; Pushpa VL; Suchitra S
J Proteome Res; 2020 Nov; 19(11):4706-4717. PubMed ID: 32960061
[TBL] [Abstract][Full Text] [Related]
62. Green and efficient one-pot three-component synthesis of novel drug-like furo[2,3-d]pyrimidines as potential active site inhibitors and putative allosteric hotspots modulators of both SARS-CoV-2 M
Mousavi H; Zeynizadeh B; Rimaz M
Bioorg Chem; 2023 Jun; 135():106390. PubMed ID: 37037129
[TBL] [Abstract][Full Text] [Related]
63. Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds.
Fischer A; Sellner M; Neranjan S; Smieško M; Lill MA
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455534
[TBL] [Abstract][Full Text] [Related]
64. Synthetic flavonoids as potential antiviral agents against SARS-CoV-2 main protease.
Batool F; Mughal EU; Zia K; Sadiq A; Naeem N; Javid A; Ul-Haq Z; Saeed M
J Biomol Struct Dyn; 2022 May; 40(8):3777-3788. PubMed ID: 33251983
[TBL] [Abstract][Full Text] [Related]
65. Potential Inhibitors of SARS-CoV-2 Main Protease (M
Verma DK; Kapoor S; Das S; Thakur KG
Biomedicines; 2022 Dec; 11(1):. PubMed ID: 36672593
[TBL] [Abstract][Full Text] [Related]
66.
Kumar B; Parasuraman P; Murthy TPK; Murahari M; Chandramohan V
J Biomol Struct Dyn; 2022 Oct; 40(17):7796-7814. PubMed ID: 33759690
[TBL] [Abstract][Full Text] [Related]
67. Microsecond MD Simulation and Multiple-Conformation Virtual Screening to Identify Potential Anti-COVID-19 Inhibitors Against SARS-CoV-2 Main Protease.
Selvaraj C; Panwar U; Dinesh DC; Boura E; Singh P; Dubey VK; Singh SK
Front Chem; 2020; 8():595273. PubMed ID: 33585398
[TBL] [Abstract][Full Text] [Related]
68. Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease.
Lu IL; Mahindroo N; Liang PH; Peng YH; Kuo CJ; Tsai KC; Hsieh HP; Chao YS; Wu SY
J Med Chem; 2006 Aug; 49(17):5154-61. PubMed ID: 16913704
[TBL] [Abstract][Full Text] [Related]
69. Reckoning a fungal metabolite, Pyranonigrin A as a potential Main protease (M
Rao P; Shukla A; Parmar P; Rawal RM; Patel B; Saraf M; Goswami D
Biophys Chem; 2020 Sep; 264():106425. PubMed ID: 32663708
[TBL] [Abstract][Full Text] [Related]
70. Screening of plant-based natural compounds as a potential COVID-19 main protease inhibitor: an
Majumder R; Mandal M
J Biomol Struct Dyn; 2022 Feb; 40(2):696-711. PubMed ID: 32897138
[TBL] [Abstract][Full Text] [Related]
71. Computational Screening of Phenylamino-Phenoxy-Quinoline Derivatives against the Main Protease of SARS-CoV-2 Using Molecular Docking and the ONIOM Method.
Patnin S; Makarasen A; Vijitphan P; Baicharoen A; Chaivisuthangkura A; Kuno M; Techasakul S
Molecules; 2022 Mar; 27(6):. PubMed ID: 35335157
[TBL] [Abstract][Full Text] [Related]
72. QSAR based virtual screening derived identification of a novel hit as a SARS CoV-229E 3CL
Jawarkar RD; Bakal RL; Zaki MEA; Al-Hussain S; Ghosh A; Gandhi A; Mukerjee N; Samad A; Masand VH; Lewaa I
Arab J Chem; 2022 Jan; 15(1):103499. PubMed ID: 34909066
[TBL] [Abstract][Full Text] [Related]
73. Traditional herbal compounds as candidates to inhibit the SARS-CoV-2 main protease: an
de Oliveira OV; Cristina Andreazza Costa M; Marques da Costa R; Giordano Viegas R; Paluch AS; Miguel Castro Ferreira M
J Biomol Struct Dyn; 2023 Mar; 41(5):1603-1616. PubMed ID: 36719113
[TBL] [Abstract][Full Text] [Related]
74. Drug Repurposing Approach against Novel Coronavirus Disease (COVID-19) through Virtual Screening Targeting SARS-CoV-2 Main Protease.
Chowdhury KH; Chowdhury MR; Mahmud S; Tareq AM; Hanif NB; Banu N; Reza ASMA; Emran TB; Simal-Gandara J
Biology (Basel); 2020 Dec; 10(1):. PubMed ID: 33374717
[TBL] [Abstract][Full Text] [Related]
75. GC-MS profiling of Bauhinia variegata major phytoconstituents with computational identification of potential lead inhibitors of SARS-CoV-2 M
More-Adate P; Lokhande KB; Swamy KV; Nagar S; Baheti A
Comput Biol Med; 2022 Aug; 147():105679. PubMed ID: 35667152
[TBL] [Abstract][Full Text] [Related]
76. Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy.
Mohammad T; Shamsi A; Anwar S; Umair M; Hussain A; Rehman MT; AlAjmi MF; Islam A; Hassan MI
Virus Res; 2020 Oct; 288():198102. PubMed ID: 32717346
[TBL] [Abstract][Full Text] [Related]
77. Systematic virtual screening in search of SARS CoV-2 inhibitors against spike glycoprotein: pharmacophore screening, molecular docking, ADMET analysis and MD simulations.
Dhameliya TM; Nagar PR; Gajjar ND
Mol Divers; 2022 Oct; 26(5):2775-2792. PubMed ID: 35132518
[TBL] [Abstract][Full Text] [Related]
78.
Al-Sehemi AG; Parulekar RS; Pannipara M; P P MA; Zubaidha PK; Bhatia MS; Mohanta TK; Al-Harrasi A
J Biomol Struct Dyn; 2023 Jan; 41(1):280-297. PubMed ID: 34809523
[TBL] [Abstract][Full Text] [Related]
79. Discovery of Novel and Highly Potent Inhibitors of SARS CoV-2 Papain-Like Protease Through Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, Molecular Dynamics Simulations, and Biological Evaluation.
Tian X; Zhao Q; Chen X; Peng Z; Tan X; Wang Q; Chen L; Yang Y
Front Pharmacol; 2022; 13():817715. PubMed ID: 35264955
[No Abstract] [Full Text] [Related]
80. Screening of natural compounds from Cyperus rotundus Linn against SARS-CoV-2 main protease (M
Kumar SB; Krishna S; Pradeep S; Mathews DE; Pattabiraman R; Murahari M; Murthy TPK
Comput Biol Med; 2021 Jul; 134():104524. PubMed ID: 34090015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]